For the year ending 2025-12-31, COEPW has $16,153,921 in assets. $2,085,764 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 5,674,302 | |||
| Marketable securities | 676,596 | |||
| Interest receivable | 7,348 | |||
| Prepaid assets | 991,903 | |||
| Total current assets | 7,350,149 | |||
| Furniture and fixtures, net | 9,873 | |||
| Investments | 7,860,083 | |||
| Intangible assets, net | 361,250 | |||
| Co-development rights, net | 554,167 | |||
| Right of use asset, net of accumulated amortization | 18,399 | |||
| Total other assets | 8,793,899 | |||
| Total assets | 16,153,921 | |||
| Accounts payable | 888,755 | |||
| Accrued expenses | 41,054 | |||
| Convertible notes payable, net of debt discount of 0 and 435,635 | 0 | |||
| Convertible notes payable, in default | 100,000 | |||
| Right of use liability, current portion | 18,875 | |||
| Customer deposit | 599,455 | |||
| Derivative liability | 0 | |||
| Other current liabilities | 120,000 | |||
| Total current liabilities | 1,768,139 | |||
| Sba loan payable | 150,000 | |||
| Derivative liability warrants | 167,625 | |||
| Right of use liability, non-current portion | 0 | |||
| Total long term liabilities | 317,625 | |||
| Total liabilities | 2,085,764 | |||
| Common stock, 0.0001 par value, 150,000,000 shares authorized, 5,746,948 and 2,116,191 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 575 | |||
| Additional paid-in capital | 127,201,691 | |||
| Common stock subscribed | 0 | |||
| Subscription receivable | 3,686,544 | |||
| Accumulated deficit | -109,953,728 | |||
| Total stockholders' equity - controlling interests | 13,561,994 | |||
| Total stockholders' equity - noncontrolling interests | 506,163 | |||
| Total stockholders' equity | 14,068,157 | |||
| Total liabilities and stockholders' equity | 16,153,921 | |||
Coeptis Therapeutics Holdings, Inc. (COEPW)
Coeptis Therapeutics Holdings, Inc. (COEPW)